Calder Biosciences Inc.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2033
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 12, 2027The maintenance fee for Conformationally-specific viral immunogens (US 11,752,191) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due Sep 12, 2027The maintenance fee for Conformationally Stabilized RSV Pre-Fusion F Proteins (US 11,926,649) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,155,023 | Conformationally Specific Viral Immunogens In force · Medium confidence | In force | Medium confidence | |
| US 11,752,191 | Conformationally-specific viral immunogens In force · From the USPTO record | In force | From the USPTO record | |
| US 9,393,297 | Influenza hemagglutinin proteins and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,993,633 | Conformationally Stabilized RSV Pre-Fusion F Proteins In force · Medium confidence | In force | Medium confidence | |
| US 10,125,172 | Conformationally Stabilized RSV Pre-Fusion F Proteins In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 11,129,887 | Influenza hemagglutinin proteins and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,926,649 | Conformationally Stabilized RSV Pre-Fusion F Proteins In force · Low confidence | In force | Low confidence | |
| US 12,703,721 | Conformationally Stabilized RSV Pre-Fusion F Proteins In force · Low confidence | In force | Low confidence | |
| US 11,267,848 | Conformationally Stabilized RSV Pre-Fusion F Proteins In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 1 patent in force now held by others · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 2 abandoned · 3 no status recorded